GoodCell

About GoodCell

GoodCell, also known as LifeVault Bio, is a life sciences and health technology company established in 2016. The company was founded by a team of science and technology innovators, including Trevor Perry, who serves as the Chief Executive Officer. GoodCell's core mission is to empower individuals to take control of their health by providing access to a platform that combines personal biobanking, diagnostics, and data analytics.

The company's primary service revolves around personal biobanking, where a person's blood cells, DNA, and plasma are cryogenically preserved for future use in personalized cellular therapies. This service is designed to be proactive and preventative, allowing members to store their healthiest cells today to potentially combat diseases that may arise in the future, such as neurodegenerative diseases, cancers, and chronic conditions like heart disease. By using an individual's own biomaterial, the service aims to eliminate the need for finding a donor match and reduces the risk of rejection. The process involves members receiving a kit, scheduling a blood draw at a partner lab like Quest Diagnostics, and having the samples processed and stored in GoodCell's CLIA/CAP certified biorepository.

GoodCell operates on a model that integrates this biobanking service with a sophisticated data and analytics platform. This platform allows for the tracking of both inherited and acquired genetic variations over time. The company aims to decode insights from these cells to advance population and personal health, identifying health risks and enabling the scientific community to advance diagnostics and drug development. Revenue is generated through its personal biobanking service and diagnostic solutions offered to individuals, with a focus on markets like concierge practices and employees with HSA & FSA accounts. The company has secured significant funding to advance its technology, including a Series B round of $17.9 million in October 2020, bringing its total raised capital to $23.5 million to support intellectual property development and the scaling of its data analytics platform.